AI has greatly enhanced the ability to predict the emergence and spread of diseases. A recent study highlights that continued advancements in this field rely on transparent data and lower training costs.
AI has already been applied in various areas of healthcare, such as diagnosing patients, assisting doctors in decision-making, and predicting individual disease risks. However, its role in epidemiology remains limited, largely due to difficulties accessing large, standardized datasets required for effectively training AI models.
Newer AI systems, however, have shown the ability to perform well even with smaller datasets, making them valuable for epidemiological research. When an outbreak occurs, assessing the severity of the disease and the likelihood of widespread transmission is crucial. Since pinpointing the exact source and timeline of an outbreak can be challenging, researchers often struggle to estimate key factors like incubation periods and transmission rates.
One method that has proven useful is Bayesian data imputation, which enhances the accuracy of parameter estimation. Integrating AI into this approach has enhanced inference capabilities and scalability.
Traditional disease transmission systems, while informative, often incur high computational costs due to their complexity. AI-driven techniques, such as variational inference, can speed up these processes, reducing the time required to generate insights to just hours. This acceleration allows for a deeper understanding of how individual transmission patterns affect broader population trends.
A potential AI approach is the GNN, which has been successfully used to predict influenza-like disease and COVID-19. Additionally, AI models have been instrumental in analyzing genomic data, helping scientists understand virus origins, mutations, and their potential to evade immune responses. These models enhance the accuracy of phylogenetic analysis, leading to a more precise characterization of infectious processes.
During outbreaks, policymakers rely on case estimates and future projections to make critical decisions. However, surveillance data is often biased due to inconsistencies in testing and reporting.
Throughout the 2019 pandemic, researchers refined AI-driven models to improve the accuracy and reliability of forecasts, enabling more informed public health interventions. Large foundation models based on deep learning have proven useful in analyzing time-bound surveillance data.
Recent AI and machine learning developments have drastically shortened the time needed to run complex epidemiological models while improving statistical precision. LLMs have also been employed to simplify intricate quantitative analyzes, tailoring insights to the needs of decision-makers.
Ethical AI use in public health remains a crucial factor. AI applications in disease prevention depend on fair and transparent data sharing, collection, and storage. While AI has shown great potential, existing models cannot often explain disease transmission mechanics and struggle to predict scenarios beyond previous scenarios and data.
Even though more data is now available than before COVID-19, many researchers are still unable to obtain regular surveillance data, which impedes progress in disease modeling. AI adoption has also been hampered by high computational costs.
Improving AI-driven epidemiology research will need addressing these issues through cost-effective model training and ethical data sharing. Quantum computing systems from various companies like D-Wave Quantum Inc. (NYSE: QBTS) are likely to accelerate this process.
NOTE TO INVESTORS: The latest news and updates relating to D-Wave Quantum Inc. (NYSE: QBTS) are available in the company’s newsroom at https://ibn.fm/QBTS
About AINewsWire
AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.
AINW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit www.AINewsWire.com
Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer
AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
Editor@AINewsWire.com
AINewsWire is powered by IBN